Seguir
Carmen griñan lison
Carmen griñan lison
Dirección de correo verificada de ugr.es - Página principal
Título
Citado por
Citado por
Año
Low adherent cancer cell subpopulations are enriched in tumorigenic and metastatic epithelial-to-mesenchymal transition-induced cancer stem-like cells
C Morata-Tarifa, G Jiménez, MA García, JM Entrena, C Griñán-Lisón, ...
Scientific reports 6 (1), 1-13, 2016
1042016
Cancer stem cell secretome in the tumor microenvironment: a key point for an effective personalized cancer treatment
J López de Andrés, C Griñán-Lisón, G Jiménez, JA Marchal
Journal of hematology & oncology 13 (1), 1-22, 2020
832020
CSC radioresistance: a therapeutic challenge to improve radiotherapy effectiveness in cancer
MA Olivares-Urbano, C Griñán-Lisón, JA Marchal, MI Núñez
Cells 9 (7), 1651, 2020
582020
Cancer suicide gene therapy: a patent review
SA Navarro, E Carrillo, C Griñán-Lisón, A Martín, M Perán, JA Marchal, ...
Expert opinion on therapeutic patents 26 (9), 1095-1104, 2016
442016
5-Fluorouracil derivatives: a patent review (2012–2014)
E Carrillo, SA Navarro, A Ramírez, MÁ García, C Griñán-Lisón, M Perán, ...
Expert opinion on therapeutic patents 25 (10), 1131-1144, 2015
412015
Volume-by-volume bioprinting of chondrocytes-alginate bioinks in high temperature thermoplastic scaffolds for cartilage regeneration
JAM JM Baena, G Jiménez, E López-Ruiz, C Antich, C Griñán-Lisón, M Perán, P ...
Exp Biol Med (Maywood). 244, 13-21, 2019
30*2019
Mesenchymal stem cell's secretome promotes selective enrichment of cancer stem-like cells with specific cytogenetic profile
G Jiménez, M Hackenberg, P Catalina, H Boulaiz, C Griñán-Lisón, ...
Cancer Letters 429, 78-88, 2018
262018
miRNAs as radio‐response biomarkers for breast cancer stem cells
C Griñán‐Lisón, MA Olivares‐Urbano, G Jiménez, E López‐Ruiz, ...
Molecular oncology 14 (3), 556-570, 2020
242020
Antioxidants for the treatment of breast cancer: Are we there yet?
C Griñan-Lison, JL Blaya-Cánovas, A López-Tejada, M Ávalos-Moreno, ...
Antioxidants 10 (2), 205, 2021
212021
What’s new in the diagnosis of pancreatic cancer: a patent review (2011-present)
H Boulaiz, MC Ramos, C Griñán-Lisón, ME García-Rubiño, F Vicente, ...
Expert Opinion on Therapeutic Patents 27 (12), 1319-1328, 2017
202017
Deregulation of cancer-stem-cell-associated miRNAs in tissues and sera of colorectal cancer patients
C Farace, A Pisano, C Griñan-Lison, G Solinas, G Jiménez, M Serra, ...
Oncotarget 11 (2), 116, 2020
192020
Validation of suitable normalizers for miR expression patterns analysis covering tumour heterogeneity
C Morata-Tarifa, M Picon-Ruiz, C Griñan-Lison, H Boulaiz, M Perán, ...
Scientific reports 7 (1), 1-9, 2017
182017
Anti-CD44-conjugated olive oil liquid nanocapsules for targeting pancreatic cancer stem cells
SA Navarro-Marchal, C Griñán-Lisón, JM Entrena, G Ruiz-Alcalá, ...
Biomacromolecules 22 (4), 1374-1388, 2021
162021
Deciphering the mechanism of action involved in enhanced suicide gene colon cancer cell killer effect mediated by gef and apoptin
B Cáceres, A Ramirez, E Carrillo, G Jimenez, C Griñán-Lisón, ...
Cancers 11 (2), 264, 2019
152019
What’s new in treatment of pancreatic cancer: a patent review (2010–2017)
MC Ramos, H Boulaiz, C Griñan-Lison, JA Marchal, F Vicente
Expert opinion on therapeutic patents 27 (11), 1251-1266, 2017
152017
The inhibitory role of mir-486-5p on csc phenotype has diagnostic and prognostic potential in colorectal cancer
A Pisano, C Griñan-Lison, C Farace, G Fiorito, G Fenu, G Jiménez, ...
Cancers 12 (11), 3432, 2020
132020
Development of a Biomimetic Hydrogel Based on Predifferentiated Mesenchymal Stem‐Cell‐Derived ECM for Cartilage Tissue Engineering
C Antich, G JimÚnez, J de Vicente, E Lˇpez‐Ruiz, C Chocarro‐Wrona, ...
Advanced Healthcare Materials 10 (8), 2001847, 2021
122021
Matrix metalloproteases and TIMPs as prognostic biomarkers in breast cancer patients treated with radiotherapy: A pilot study
MA Olivares‐Urbano, C Griñán‐Lisón, M Zurita, R Del Moral, ...
Journal of cellular and molecular medicine 24 (1), 139-148, 2020
122020
Radiation and stemness phenotype may influence individual breast cancer outcomes: the crucial role of mmps and microenvironment
MA Olivares-Urbano, C Griñán-Lisón, S Ríos-Arrabal, F Artacho-Cordón, ...
Cancers 11 (11), 1781, 2019
92019
Pancreatic (pro) enzymes treatment suppresses BXPC-3 pancreatic Cancer Stem Cell subpopulation and impairs tumour engrafting
P Hernández-Camarero, E López-Ruiz, C Griñán-Lisón, MÁ García, ...
Scientific reports 9 (1), 1-17, 2019
92019
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20